Molecular genetic alterations of c-myc oncogene in superficial and locally advanced bladder cancer

Eur Urol. 1998;33(4):424-30. doi: 10.1159/000019629.

Abstract

Objective: Gene activation and altered expression of cellular proto-oncogene are important mechanisms implicated in initiation and development processes of human cancer. It has already been shown that c-myc oncogene is implicated in the control of cell proliferation, apoptosis and differentiation.

Methods: We have determined the methylation status, the presence of genetic amplification and the presence of m-RNA overexpression of c-myc gene in 31 samples from patients with bladder carcinomas.

Results: Our data demonstrated the presence of c-myc gene amplification only in 5 of 15 superficial bladder carcinomas (p < 0.05). On the other hand, we did not find statistical significant correlation between the methylation, expression of c-myc gene and the clinical-histopathological parameters. A significant correlation (p < 0.05) was found between the methylation pattern and m-RNA overexpression of c-myc oncogene.

Conclusion: We demonstrate aberrant c-myc gene status in human bladder cancer. This oncogene is altered at different levels in bladder carcinoma genesis and progression.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • DNA Methylation
  • Disease Progression
  • Female
  • Gene Amplification
  • Gene Expression Regulation, Neoplastic*
  • Genes, myc / genetics*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Proto-Oncogene Mas
  • RNA, Messenger / analysis*
  • Reference Values
  • Sensitivity and Specificity
  • Transcriptional Activation
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms / genetics*
  • Urinary Bladder Neoplasms / pathology

Substances

  • MAS1 protein, human
  • Proto-Oncogene Mas
  • RNA, Messenger